Clin2
NCT07500207Likely a fitEnrolling by invitation

Rabies vaccine trial for people aged 10 to 60

Rabies Prevention

Part of Infections clinical trials.

This trial tests a new lyophilized rabies vaccine to see how well it works and how safe it is. It is for people who have not been vaccinated against rabies recently and have not been bitten or scratched by an animal that broke the skin in the past year.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
3,000 people
Ages
10 years to 60 years
Study type
Interventional

Who can take part

  • You are between 10 and 60 years old.
  • You or your guardian can understand and sign the consent form.
  • You don't have a fever (temperature over 37°C) on the day of vaccination.
  • You haven't had a rabies vaccine or rabies antibodies before.
  • You haven't been bitten or scratched (with broken skin) by a dog or other mammal in the past year.
  • You are not pregnant, breastfeeding, or planning pregnancy during the trial and for 6 months after.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07416110Not yet recruiting· Phase 3
Testing different batches of the rabies vaccine in healthy adults

This trial tests whether different batches of a rabies vaccine produce the same immune response. You would receive the vaccine and have blood tests to check your antibody levels, helping ensure the vaccine works consistently.

Deyang
NCT07338786Enrolling by invitation· Phase 1
Rabies vaccine safety trial for ages 10 to 60

This trial tests a freeze-dried rabies vaccine to see how safe it is when given on different schedules. It may be an option for people who need protection from rabies.

Xuzhou, Jiangsu
NCT07028801Not yet recruiting· Phase 3
New rabies vaccine for people ages 10 to 60

This trial tests a new freeze-dried rabies vaccine grown in human cells. It aims to confirm the vaccine is safe and works well for people aged 10 to 60 who have not been vaccinated against rabies before and have not been recently bitten by a rabid animal. By joining, you help ensure that a reliable vaccine is available to protect against this serious disease.

Zhengzhou, Henan
NCT07021703Recruiting· Phase 1
Rabies vaccine trial for people aged 10 to 60

This trial tests a new rabies vaccine to see if it's safe and effective. It's for people who haven't been vaccinated against rabies or been bitten by a rabies-risk animal recently.

Zhengzhou, Henan
NCT07055880Not yet recruiting· Phase 2
Rabies vaccine doses for adults 18 to 59

This trial tests different doses of a rabies vaccine to see how well they protect against rabies and how safe they are. It's for healthy adults who may need rabies protection, for example after an animal bite or as routine prevention.

Karachi
NCT07445815Not yet recruiting· Phase 2
Testing a lab-made antibody for rabies prevention in healthy adults

This trial tests a new rabies-prevention medicine made in a lab. It is for healthy people, not those who have been bitten, and aims to see if the injection is safe and how the body handles it.

Lanzhou, Gansu

Hear when a new Rabies Prevention trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.